Vertex Pharmaceuticals recently announced that the FDA has granted Breakthrough Therapy Designation to povetacicept for IgA ...
Ratings for Vertex (NASDAQ: VERX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and ...
Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...
Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
Kapiva’s key categories include products for diabetes, energy, sports, nutrition, liver and heart. These products are sold ...
The company plans to deploy the primary capital to strengthen research and development and manufacturing, step up brand ...
However, when multiple insiders purchase stock, like in Vertex Resource Group Ltd.'s (CVE:VTX) instance, it's good news for shareholders. While insider transactions are not the most important thing ...
Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of ...
Kapiva, a healthcare brand focused on Ayurveda-based products, has raised $60 million in a Series D funding round. The round ...
Daily Times on MSN
CBD unveils Project Vertex - the future face of business in Punjab
AM ...
Vertex (VRTX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth ...
Stockhead on MSN
Vertex drives Reward underground mine on four mining fronts
Vertex Minerals (ASX:VTX) is still in the early stages of developing its underground mine, and while the production ramp-up was slowed by delays in high-voltage equipment delivery and commissioning, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback